Prime Medicine (PRME) Revenue (2024 - 2026)

Prime Medicine's (PRME) quarterly Revenue came in at $856000.0 in Q1 2026, down 41.13% YoY from $1.5 million in Q1 2025, and up 2.15% on a QoQ basis from $838000.0 in Q4 2025.

Prime Medicine (PRME) Revenue (2024 - 2026) Analysis & Trends

Prime Medicine (PRME) has 3 years of Revenue data on file, last reported at $856000.0 in Q1 2026.

  • Quarterly Revenue fell 41.13% year-over-year to $856000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 4.89% YoY) and the FY2025 annual result came in at $4.6 million, up 55.28% from the prior year.
  • Revenue improved to $856000.0 in Q1 2026, from $838000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $2.2 million in Q4 2024 to a low of $209000.0 in Q3 2024.
  • A 3-year average of $1.1 million and a median of $985500.0 in 2025 frame the typical range for Revenue.
  • The widest YoY moves for Revenue: up 486.12% in 2025, down 61.61% in 2025.
  • Tracing PRME's Revenue over 3 years: stood at $2.2 million in 2024, then tumbled by 61.61% to $838000.0 in 2025, then advanced by 2.15% to $856000.0 in 2026.
  • The last three Revenue figures came in at $856000.0 (Q1 2026), $838000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.56 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.71 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,001.92
7 Royalty Pharma 33.72 Bn 35.84 Bn - 674.14 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.29 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 425.49 Mn
10 Prime Medicine 558.48 Mn 558.48 Mn - 1.15 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.15 Mn
Mar 31, 2026 856,000.00
Dec 31, 2025 838,000.00
Sep 30, 2025 1.23 Mn
Jun 30, 2025 1.12 Mn
Mar 31, 2025 1.45 Mn
Dec 31, 2024 2.18 Mn
Sep 30, 2024 209,000.00
Mar 31, 2024 591,000.00